Takayuki Takahama

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Case reports in medicine

Cancer

Molecular oncology

Kindai University

Kindai University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kindai University Apr 01 2013

Japan

Assistant Professor :: Faculty of Medicine

Education History

Kindai University Apr 01 2015 - Mar 31 2018

Japan

PHD :: Faculty of Medicine

Publications

Luis G Paz-Ares, Oscar Juan Vidal, Giannis S Mountzios, Enriqueta Felip Font, Niels Reinmuth, Filippo de Marinis, Nicolas Girard, Vipul M Patel, Takayuki Takahama, Scott P Owen, Douglas M Reznick, Firas B Badin, Irfan Cicin, Sabeen Mekan, Riddhi Patel, Eric Zhang, Divyadeep Karumanchi, Marina-Chiara Garassino
Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Luis G Paz-Ares, Oscar Juan Vidal, Giannis S Mountzios, Enriqueta Felip Font, Niels Reinmuth, Filippo de Marinis, Nicolas Girard, Vipul M Patel, Takayuki Takahama, Scott P Owen, Douglas M Reznick, Firas B Badin, Irfan Cicin, Sabeen Mekan, Riddhi Patel, Eric Zhang, Divyadeep Karumanchi, Marina-Chiara Garassino
Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Luis G Paz-Ares, Oscar Juan Vidal, Giannis S Mountzios, Enriqueta Felip Font, Niels Reinmuth, Filippo de Marinis, Nicolas Girard, Vipul M Patel, Takayuki Takahama, Scott P Owen, Douglas M Reznick, Firas B Badin, Irfan Cicin, Sabeen Mekan, Riddhi Patel, Eric Zhang, Divyadeep Karumanchi, Marina-Chiara Garassino
Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Luis G Paz-Ares, Oscar Juan Vidal, Giannis S Mountzios, Enriqueta Felip Font, Niels Reinmuth, Filippo de Marinis, Nicolas Girard, Vipul M Patel, Takayuki Takahama, Scott P Owen, Douglas M Reznick, Firas B Badin, Irfan Cicin, Sabeen Mekan, Riddhi Patel, Eric Zhang, Divyadeep Karumanchi, Marina-Chiara Garassino
Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Yasuo Otsuka, Yoriaki Komeda, Masayuki Takeda, Takayuki Takahama, Masashi Kono, Mamoru Takenaka, Satoru Hagiwara, Naoshi Nishida, Hiroshi Kashida, Masatoshi Kudo
Long-Term Survival of More than 5 Years with Maintenance Therapy Using Single-Agent Pemetrexed in a Patient with Diffuse Malignant Peritoneal Mesothelioma. Case reports in medicine 2023 (2023)
Yasuo Otsuka, Yoriaki Komeda, Masayuki Takeda, Takayuki Takahama, Masashi Kono, Mamoru Takenaka, Satoru Hagiwara, Naoshi Nishida, Hiroshi Kashida, Masatoshi Kudo
Long-Term Survival of More than 5 Years with Maintenance Therapy Using Single-Agent Pemetrexed in a Patient with Diffuse Malignant Peritoneal Mesothelioma. Case reports in medicine 2023 (2023)
Takayuki Takahama, Koichi Azuma, Mototsugu Shimokawa, Masayuki Takeda, Hidenobu Ishii, Terufumi Kato, Haruhiro Saito, Haruko Daga, Yuko Tsuboguchi, Isamu Okamoto, Kohei Otsubo, Hiroaki Akamatsu, Shunsuke Teraoka, Toshiaki Takahashi, Akira Ono, Tatsuo Ohira, Toshihide Yokoyama, Kazuko Sakai, Nobuyuki Yamamoto, Kazuto Nishio, Kazuhiko Nakagawa
Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M-positive non-small cell lung cancer: West Japan Oncology Group 8815L/LPS study. Cancer 126 (9) (2020)
Kazuko Sakai, Takayuki Takahama, Mototsugu Shimokawa, Koichi Azuma, Masayuki Takeda, Terufumi Kato, Haruko Daga, Isamu Okamoto, Hiroaki Akamatsu, Shunsuke Teraoka, Akira Ono, Tatsuo Ohira, Toshihide Yokoyama, Nobuyuki Yamamoto, Kazuhiko Nakagawa, Kazuto Nishio
Predicting osimertinib-treatment outcomes through EGFR mutant-fraction monitoring in the circulating tumor DNA of EGFR T790M-positive patients with non-small cell lung cancer (WJOG8815L). Molecular oncology 15 (1) (2020)

Takayuki Takahama.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Takayuki Takahama